Clinical trial

REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis

NCT05182892

Study summary

ClinicalTrials.gov

REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Change of stimulation amplitudes in dopaminergic OFF drug state Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-12-13

PhaseNA

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

Change of stimulation amplitudes in dopaminergic OFF drug stateOTHER

Sponsors & collaborators

Insel Gruppe AG, University Hospital Bernlead sponsor

Czech Technical University in Praguecollaborator

Mapped research locations

PragueCzechia1 BernSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05182892 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.